Targeting protein kinase CK2 in the treatment of cholangiocarcinoma. (2021)
Attributed to:
PRH/HHEX in intrahepatic cholangiocarcinoma, disease progression and response to chemotherapeutics.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.37349/etat.2021.00055
PubMed Identifier: 36045705
Publication URI: http://europepmc.org/abstract/MED/36045705
Type: Journal Article/Review
Volume: 2
Parent Publication: Exploration of targeted anti-tumor therapy
Issue: 5
ISSN: 2692-3114